Crossmark

Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.07.030

Published Print: 2018-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Messina, Carlo

Messina, Marco

Boccardo, Francesco
License Information

Text and Data Mining valid from 2018-01-01
More Information

This article is maintained by: Elsevier

Article Title: Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.07.030

Content Type: simple-article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.